Global Hepatic Encephalopathy Treatment Supply, Demand and Key Producers, 2023-2029
The global Hepatic Encephalopathy Treatment market size is expected to reach $ 2332.8 million by 2029, rising at a market growth of 6.2% CAGR during the forecast period (2023-2029).
Hepatic encephalopathy (HE) treatment aims to manage the symptoms and underlying causes of the condition. HE is a condition where the liver is unable to remove toxins from the bloodstream effectively, leading to a buildup of toxins in the brain. The condition can range from mild to severe, with symptoms such as confusion, personality changes, tremors, and even coma.
This report studies the global Hepatic Encephalopathy Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hepatic Encephalopathy Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hepatic Encephalopathy Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hepatic Encephalopathy Treatment total production and demand, 2018-2029, (K Units)
Global Hepatic Encephalopathy Treatment total production value, 2018-2029, (USD Million)
Global Hepatic Encephalopathy Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hepatic Encephalopathy Treatment domestic production, consumption, key domestic manufacturers and share
Global Hepatic Encephalopathy Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment production by Route, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hepatic Encephalopathy Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services and Takeda Pharmaceutical Company Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hepatic Encephalopathy Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Route, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hepatic Encephalopathy Treatment Market, By Region:
1. How big is the global Hepatic Encephalopathy Treatment market?
2. What is the demand of the global Hepatic Encephalopathy Treatment market?
3. What is the year over year growth of the global Hepatic Encephalopathy Treatment market?
4. What is the production and production value of the global Hepatic Encephalopathy Treatment market?
5. Who are the key producers in the global Hepatic Encephalopathy Treatment market?
6. What are the growth factors driving the market demand?
Hepatic encephalopathy (HE) treatment aims to manage the symptoms and underlying causes of the condition. HE is a condition where the liver is unable to remove toxins from the bloodstream effectively, leading to a buildup of toxins in the brain. The condition can range from mild to severe, with symptoms such as confusion, personality changes, tremors, and even coma.
This report studies the global Hepatic Encephalopathy Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hepatic Encephalopathy Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hepatic Encephalopathy Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hepatic Encephalopathy Treatment total production and demand, 2018-2029, (K Units)
Global Hepatic Encephalopathy Treatment total production value, 2018-2029, (USD Million)
Global Hepatic Encephalopathy Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hepatic Encephalopathy Treatment domestic production, consumption, key domestic manufacturers and share
Global Hepatic Encephalopathy Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment production by Route, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hepatic Encephalopathy Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hepatic Encephalopathy Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services and Takeda Pharmaceutical Company Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hepatic Encephalopathy Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Route, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hepatic Encephalopathy Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- Injectable
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Mallinckrodt Pharmaceuticals
- Salix Pharmaceuticals
- GlaxoSmithKline plc.
- Pfizer Inc.
- ASKA Pharmaceutical Co., Ltd.
- Bausch Health
- Johnson & Johnson Services, Inc.
- Janssen Global Services
- Takeda Pharmaceutical Company Limited
- Merck & Co., Inc.
1. How big is the global Hepatic Encephalopathy Treatment market?
2. What is the demand of the global Hepatic Encephalopathy Treatment market?
3. What is the year over year growth of the global Hepatic Encephalopathy Treatment market?
4. What is the production and production value of the global Hepatic Encephalopathy Treatment market?
5. Who are the key producers in the global Hepatic Encephalopathy Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hepatic Encephalopathy Treatment Introduction
1.2 World Hepatic Encephalopathy Treatment Supply & Forecast
1.2.1 World Hepatic Encephalopathy Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Hepatic Encephalopathy Treatment Production (2018-2029)
1.2.3 World Hepatic Encephalopathy Treatment Pricing Trends (2018-2029)
1.3 World Hepatic Encephalopathy Treatment Production by Region (Based on Production Site)
1.3.1 World Hepatic Encephalopathy Treatment Production Value by Region (2018-2029)
1.3.2 World Hepatic Encephalopathy Treatment Production by Region (2018-2029)
1.3.3 World Hepatic Encephalopathy Treatment Average Price by Region (2018-2029)
1.3.4 North America Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.5 Europe Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.6 China Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.7 Japan Hepatic Encephalopathy Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hepatic Encephalopathy Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hepatic Encephalopathy Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hepatic Encephalopathy Treatment Demand (2018-2029)
2.2 World Hepatic Encephalopathy Treatment Consumption by Region
2.2.1 World Hepatic Encephalopathy Treatment Consumption by Region (2018-2023)
2.2.2 World Hepatic Encephalopathy Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.4 China Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.5 Europe Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.6 Japan Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.7 South Korea Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.8 ASEAN Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.9 India Hepatic Encephalopathy Treatment Consumption (2018-2029)
3 WORLD HEPATIC ENCEPHALOPATHY TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hepatic Encephalopathy Treatment Production Value by Manufacturer (2018-2023)
3.2 World Hepatic Encephalopathy Treatment Production by Manufacturer (2018-2023)
3.3 World Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Hepatic Encephalopathy Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hepatic Encephalopathy Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hepatic Encephalopathy Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Hepatic Encephalopathy Treatment in 2022
3.6 Hepatic Encephalopathy Treatment Market: Overall Company Footprint Analysis
3.6.1 Hepatic Encephalopathy Treatment Market: Region Footprint
3.6.2 Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
3.6.3 Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hepatic Encephalopathy Treatment Production Value Comparison
4.1.1 United States VS China: Hepatic Encephalopathy Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hepatic Encephalopathy Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hepatic Encephalopathy Treatment Production Comparison
4.2.1 United States VS China: Hepatic Encephalopathy Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hepatic Encephalopathy Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hepatic Encephalopathy Treatment Consumption Comparison
4.3.1 United States VS China: Hepatic Encephalopathy Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hepatic Encephalopathy Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hepatic Encephalopathy Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
4.5 China Based Hepatic Encephalopathy Treatment Manufacturers and Market Share
4.5.1 China Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
4.6 Rest of World Based Hepatic Encephalopathy Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
5 MARKET ANALYSIS BY ROUTE
5.1 World Hepatic Encephalopathy Treatment Market Size Overview by Route: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Route
5.2.1 Oral
5.2.2 Injectable
5.3 Market Segment by Route
5.3.1 World Hepatic Encephalopathy Treatment Production by Route (2018-2029)
5.3.2 World Hepatic Encephalopathy Treatment Production Value by Route (2018-2029)
5.3.3 World Hepatic Encephalopathy Treatment Average Price by Route (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hepatic Encephalopathy Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Segment by Application
6.3.1 World Hepatic Encephalopathy Treatment Production by Application (2018-2029)
6.3.2 World Hepatic Encephalopathy Treatment Production Value by Application (2018-2029)
6.3.3 World Hepatic Encephalopathy Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Details
7.1.2 Mallinckrodt Pharmaceuticals Major Business
7.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
7.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.1.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Salix Pharmaceuticals
7.2.1 Salix Pharmaceuticals Details
7.2.2 Salix Pharmaceuticals Major Business
7.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
7.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Salix Pharmaceuticals Recent Developments/Updates
7.2.6 Salix Pharmaceuticals Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline plc.
7.3.1 GlaxoSmithKline plc. Details
7.3.2 GlaxoSmithKline plc. Major Business
7.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
7.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GlaxoSmithKline plc. Recent Developments/Updates
7.3.6 GlaxoSmithKline plc. Competitive Strengths & Weaknesses
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Details
7.4.2 Pfizer Inc. Major Business
7.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
7.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Inc. Recent Developments/Updates
7.4.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.5 ASKA Pharmaceutical Co., Ltd.
7.5.1 ASKA Pharmaceutical Co., Ltd. Details
7.5.2 ASKA Pharmaceutical Co., Ltd. Major Business
7.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
7.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5.6 ASKA Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bausch Health
7.6.1 Bausch Health Details
7.6.2 Bausch Health Major Business
7.6.3 Bausch Health Hepatic Encephalopathy Treatment Product and Services
7.6.4 Bausch Health Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Recent Developments/Updates
7.6.6 Bausch Health Competitive Strengths & Weaknesses
7.7 Johnson & Johnson Services, Inc.
7.7.1 Johnson & Johnson Services, Inc. Details
7.7.2 Johnson & Johnson Services, Inc. Major Business
7.7.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
7.7.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
7.7.6 Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
7.8 Janssen Global Services
7.8.1 Janssen Global Services Details
7.8.2 Janssen Global Services Major Business
7.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
7.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Janssen Global Services Recent Developments/Updates
7.8.6 Janssen Global Services Competitive Strengths & Weaknesses
7.9 Takeda Pharmaceutical Company Limited
7.9.1 Takeda Pharmaceutical Company Limited Details
7.9.2 Takeda Pharmaceutical Company Limited Major Business
7.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
7.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.9.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Details
7.10.2 Merck & Co., Inc. Major Business
7.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
7.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Merck & Co., Inc. Recent Developments/Updates
7.10.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hepatic Encephalopathy Treatment Industry Chain
8.2 Hepatic Encephalopathy Treatment Upstream Analysis
8.2.1 Hepatic Encephalopathy Treatment Core Raw Materials
8.2.2 Main Manufacturers of Hepatic Encephalopathy Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hepatic Encephalopathy Treatment Production Mode
8.6 Hepatic Encephalopathy Treatment Procurement Model
8.7 Hepatic Encephalopathy Treatment Industry Sales Model and Sales Channels
8.7.1 Hepatic Encephalopathy Treatment Sales Model
8.7.2 Hepatic Encephalopathy Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hepatic Encephalopathy Treatment Introduction
1.2 World Hepatic Encephalopathy Treatment Supply & Forecast
1.2.1 World Hepatic Encephalopathy Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Hepatic Encephalopathy Treatment Production (2018-2029)
1.2.3 World Hepatic Encephalopathy Treatment Pricing Trends (2018-2029)
1.3 World Hepatic Encephalopathy Treatment Production by Region (Based on Production Site)
1.3.1 World Hepatic Encephalopathy Treatment Production Value by Region (2018-2029)
1.3.2 World Hepatic Encephalopathy Treatment Production by Region (2018-2029)
1.3.3 World Hepatic Encephalopathy Treatment Average Price by Region (2018-2029)
1.3.4 North America Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.5 Europe Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.6 China Hepatic Encephalopathy Treatment Production (2018-2029)
1.3.7 Japan Hepatic Encephalopathy Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hepatic Encephalopathy Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hepatic Encephalopathy Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hepatic Encephalopathy Treatment Demand (2018-2029)
2.2 World Hepatic Encephalopathy Treatment Consumption by Region
2.2.1 World Hepatic Encephalopathy Treatment Consumption by Region (2018-2023)
2.2.2 World Hepatic Encephalopathy Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.4 China Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.5 Europe Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.6 Japan Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.7 South Korea Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.8 ASEAN Hepatic Encephalopathy Treatment Consumption (2018-2029)
2.9 India Hepatic Encephalopathy Treatment Consumption (2018-2029)
3 WORLD HEPATIC ENCEPHALOPATHY TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hepatic Encephalopathy Treatment Production Value by Manufacturer (2018-2023)
3.2 World Hepatic Encephalopathy Treatment Production by Manufacturer (2018-2023)
3.3 World Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Hepatic Encephalopathy Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hepatic Encephalopathy Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hepatic Encephalopathy Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Hepatic Encephalopathy Treatment in 2022
3.6 Hepatic Encephalopathy Treatment Market: Overall Company Footprint Analysis
3.6.1 Hepatic Encephalopathy Treatment Market: Region Footprint
3.6.2 Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
3.6.3 Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hepatic Encephalopathy Treatment Production Value Comparison
4.1.1 United States VS China: Hepatic Encephalopathy Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hepatic Encephalopathy Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hepatic Encephalopathy Treatment Production Comparison
4.2.1 United States VS China: Hepatic Encephalopathy Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hepatic Encephalopathy Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hepatic Encephalopathy Treatment Consumption Comparison
4.3.1 United States VS China: Hepatic Encephalopathy Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hepatic Encephalopathy Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hepatic Encephalopathy Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
4.5 China Based Hepatic Encephalopathy Treatment Manufacturers and Market Share
4.5.1 China Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
4.6 Rest of World Based Hepatic Encephalopathy Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023)
5 MARKET ANALYSIS BY ROUTE
5.1 World Hepatic Encephalopathy Treatment Market Size Overview by Route: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Route
5.2.1 Oral
5.2.2 Injectable
5.3 Market Segment by Route
5.3.1 World Hepatic Encephalopathy Treatment Production by Route (2018-2029)
5.3.2 World Hepatic Encephalopathy Treatment Production Value by Route (2018-2029)
5.3.3 World Hepatic Encephalopathy Treatment Average Price by Route (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hepatic Encephalopathy Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Segment by Application
6.3.1 World Hepatic Encephalopathy Treatment Production by Application (2018-2029)
6.3.2 World Hepatic Encephalopathy Treatment Production Value by Application (2018-2029)
6.3.3 World Hepatic Encephalopathy Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Details
7.1.2 Mallinckrodt Pharmaceuticals Major Business
7.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
7.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.1.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Salix Pharmaceuticals
7.2.1 Salix Pharmaceuticals Details
7.2.2 Salix Pharmaceuticals Major Business
7.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
7.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Salix Pharmaceuticals Recent Developments/Updates
7.2.6 Salix Pharmaceuticals Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline plc.
7.3.1 GlaxoSmithKline plc. Details
7.3.2 GlaxoSmithKline plc. Major Business
7.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
7.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GlaxoSmithKline plc. Recent Developments/Updates
7.3.6 GlaxoSmithKline plc. Competitive Strengths & Weaknesses
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Details
7.4.2 Pfizer Inc. Major Business
7.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
7.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Inc. Recent Developments/Updates
7.4.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.5 ASKA Pharmaceutical Co., Ltd.
7.5.1 ASKA Pharmaceutical Co., Ltd. Details
7.5.2 ASKA Pharmaceutical Co., Ltd. Major Business
7.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
7.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5.6 ASKA Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bausch Health
7.6.1 Bausch Health Details
7.6.2 Bausch Health Major Business
7.6.3 Bausch Health Hepatic Encephalopathy Treatment Product and Services
7.6.4 Bausch Health Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Recent Developments/Updates
7.6.6 Bausch Health Competitive Strengths & Weaknesses
7.7 Johnson & Johnson Services, Inc.
7.7.1 Johnson & Johnson Services, Inc. Details
7.7.2 Johnson & Johnson Services, Inc. Major Business
7.7.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
7.7.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
7.7.6 Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
7.8 Janssen Global Services
7.8.1 Janssen Global Services Details
7.8.2 Janssen Global Services Major Business
7.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
7.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Janssen Global Services Recent Developments/Updates
7.8.6 Janssen Global Services Competitive Strengths & Weaknesses
7.9 Takeda Pharmaceutical Company Limited
7.9.1 Takeda Pharmaceutical Company Limited Details
7.9.2 Takeda Pharmaceutical Company Limited Major Business
7.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
7.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.9.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Details
7.10.2 Merck & Co., Inc. Major Business
7.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
7.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Merck & Co., Inc. Recent Developments/Updates
7.10.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hepatic Encephalopathy Treatment Industry Chain
8.2 Hepatic Encephalopathy Treatment Upstream Analysis
8.2.1 Hepatic Encephalopathy Treatment Core Raw Materials
8.2.2 Main Manufacturers of Hepatic Encephalopathy Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hepatic Encephalopathy Treatment Production Mode
8.6 Hepatic Encephalopathy Treatment Procurement Model
8.7 Hepatic Encephalopathy Treatment Industry Sales Model and Sales Channels
8.7.1 Hepatic Encephalopathy Treatment Sales Model
8.7.2 Hepatic Encephalopathy Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hepatic Encephalopathy Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hepatic Encephalopathy Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hepatic Encephalopathy Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Hepatic Encephalopathy Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Hepatic Encephalopathy Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Hepatic Encephalopathy Treatment Production Market Share by Region (2018-2023)
Table 9. World Hepatic Encephalopathy Treatment Production Market Share by Region (2024-2029)
Table 10. World Hepatic Encephalopathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hepatic Encephalopathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hepatic Encephalopathy Treatment Major Market Trends
Table 13. World Hepatic Encephalopathy Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hepatic Encephalopathy Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Hepatic Encephalopathy Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hepatic Encephalopathy Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hepatic Encephalopathy Treatment Producers in 2022
Table 18. World Hepatic Encephalopathy Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hepatic Encephalopathy Treatment Producers in 2022
Table 20. World Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hepatic Encephalopathy Treatment Company Evaluation Quadrant
Table 22. World Hepatic Encephalopathy Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hepatic Encephalopathy Treatment Production Site of Key Manufacturer
Table 24. Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
Table 25. Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
Table 26. Hepatic Encephalopathy Treatment Competitive Factors
Table 27. Hepatic Encephalopathy Treatment New Entrant and Capacity Expansion Plans
Table 28. Hepatic Encephalopathy Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Hepatic Encephalopathy Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hepatic Encephalopathy Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hepatic Encephalopathy Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 37. China Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 47. World Hepatic Encephalopathy Treatment Production Value by Route, (USD Million), 2018 & 2022 & 2029
Table 48. World Hepatic Encephalopathy Treatment Production by Route (2018-2023) & (K Units)
Table 49. World Hepatic Encephalopathy Treatment Production by Route (2024-2029) & (K Units)
Table 50. World Hepatic Encephalopathy Treatment Production Value by Route (2018-2023) & (USD Million)
Table 51. World Hepatic Encephalopathy Treatment Production Value by Route (2024-2029) & (USD Million)
Table 52. World Hepatic Encephalopathy Treatment Average Price by Route (2018-2023) & (US$/Unit)
Table 53. World Hepatic Encephalopathy Treatment Average Price by Route (2024-2029) & (US$/Unit)
Table 54. World Hepatic Encephalopathy Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hepatic Encephalopathy Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Hepatic Encephalopathy Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Hepatic Encephalopathy Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hepatic Encephalopathy Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hepatic Encephalopathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hepatic Encephalopathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Mallinckrodt Pharmaceuticals Major Business
Table 63. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 64. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 66. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Salix Pharmaceuticals Major Business
Table 69. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 70. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Salix Pharmaceuticals Recent Developments/Updates
Table 72. Salix Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline plc. Major Business
Table 75. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
Table 76. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline plc. Recent Developments/Updates
Table 78. GlaxoSmithKline plc. Competitive Strengths & Weaknesses
Table 79. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc. Major Business
Table 81. Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
Table 82. Pfizer Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Inc. Recent Developments/Updates
Table 84. Pfizer Inc. Competitive Strengths & Weaknesses
Table 85. ASKA Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. ASKA Pharmaceutical Co., Ltd. Major Business
Table 87. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
Table 88. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. ASKA Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Major Business
Table 93. Bausch Health Hepatic Encephalopathy Treatment Product and Services
Table 94. Bausch Health Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bausch Health Recent Developments/Updates
Table 96. Bausch Health Competitive Strengths & Weaknesses
Table 97. Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Services, Inc. Major Business
Table 99. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
Table 100. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 102. Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
Table 103. Janssen Global Services Basic Information, Manufacturing Base and Competitors
Table 104. Janssen Global Services Major Business
Table 105. Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
Table 106. Janssen Global Services Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Janssen Global Services Recent Developments/Updates
Table 108. Janssen Global Services Competitive Strengths & Weaknesses
Table 109. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 110. Takeda Pharmaceutical Company Limited Major Business
Table 111. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
Table 112. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 114. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 115. Merck & Co., Inc. Major Business
Table 116. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
Table 117. Merck & Co., Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Hepatic Encephalopathy Treatment Upstream (Raw Materials)
Table 119. Hepatic Encephalopathy Treatment Typical Customers
Table 120. Hepatic Encephalopathy Treatment Typical Distributors
Table 1. World Hepatic Encephalopathy Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hepatic Encephalopathy Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hepatic Encephalopathy Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Hepatic Encephalopathy Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Hepatic Encephalopathy Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Hepatic Encephalopathy Treatment Production Market Share by Region (2018-2023)
Table 9. World Hepatic Encephalopathy Treatment Production Market Share by Region (2024-2029)
Table 10. World Hepatic Encephalopathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hepatic Encephalopathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hepatic Encephalopathy Treatment Major Market Trends
Table 13. World Hepatic Encephalopathy Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hepatic Encephalopathy Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Hepatic Encephalopathy Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hepatic Encephalopathy Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hepatic Encephalopathy Treatment Producers in 2022
Table 18. World Hepatic Encephalopathy Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hepatic Encephalopathy Treatment Producers in 2022
Table 20. World Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hepatic Encephalopathy Treatment Company Evaluation Quadrant
Table 22. World Hepatic Encephalopathy Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hepatic Encephalopathy Treatment Production Site of Key Manufacturer
Table 24. Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
Table 25. Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
Table 26. Hepatic Encephalopathy Treatment Competitive Factors
Table 27. Hepatic Encephalopathy Treatment New Entrant and Capacity Expansion Plans
Table 28. Hepatic Encephalopathy Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Hepatic Encephalopathy Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hepatic Encephalopathy Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hepatic Encephalopathy Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 37. China Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Hepatic Encephalopathy Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share (2018-2023)
Table 47. World Hepatic Encephalopathy Treatment Production Value by Route, (USD Million), 2018 & 2022 & 2029
Table 48. World Hepatic Encephalopathy Treatment Production by Route (2018-2023) & (K Units)
Table 49. World Hepatic Encephalopathy Treatment Production by Route (2024-2029) & (K Units)
Table 50. World Hepatic Encephalopathy Treatment Production Value by Route (2018-2023) & (USD Million)
Table 51. World Hepatic Encephalopathy Treatment Production Value by Route (2024-2029) & (USD Million)
Table 52. World Hepatic Encephalopathy Treatment Average Price by Route (2018-2023) & (US$/Unit)
Table 53. World Hepatic Encephalopathy Treatment Average Price by Route (2024-2029) & (US$/Unit)
Table 54. World Hepatic Encephalopathy Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hepatic Encephalopathy Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Hepatic Encephalopathy Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Hepatic Encephalopathy Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hepatic Encephalopathy Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hepatic Encephalopathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hepatic Encephalopathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Mallinckrodt Pharmaceuticals Major Business
Table 63. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 64. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 66. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Salix Pharmaceuticals Major Business
Table 69. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 70. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Salix Pharmaceuticals Recent Developments/Updates
Table 72. Salix Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline plc. Major Business
Table 75. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
Table 76. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline plc. Recent Developments/Updates
Table 78. GlaxoSmithKline plc. Competitive Strengths & Weaknesses
Table 79. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc. Major Business
Table 81. Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
Table 82. Pfizer Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Inc. Recent Developments/Updates
Table 84. Pfizer Inc. Competitive Strengths & Weaknesses
Table 85. ASKA Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. ASKA Pharmaceutical Co., Ltd. Major Business
Table 87. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
Table 88. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. ASKA Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 92. Bausch Health Major Business
Table 93. Bausch Health Hepatic Encephalopathy Treatment Product and Services
Table 94. Bausch Health Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bausch Health Recent Developments/Updates
Table 96. Bausch Health Competitive Strengths & Weaknesses
Table 97. Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Services, Inc. Major Business
Table 99. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
Table 100. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 102. Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
Table 103. Janssen Global Services Basic Information, Manufacturing Base and Competitors
Table 104. Janssen Global Services Major Business
Table 105. Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
Table 106. Janssen Global Services Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Janssen Global Services Recent Developments/Updates
Table 108. Janssen Global Services Competitive Strengths & Weaknesses
Table 109. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 110. Takeda Pharmaceutical Company Limited Major Business
Table 111. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
Table 112. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 114. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 115. Merck & Co., Inc. Major Business
Table 116. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
Table 117. Merck & Co., Inc. Hepatic Encephalopathy Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Hepatic Encephalopathy Treatment Upstream (Raw Materials)
Table 119. Hepatic Encephalopathy Treatment Typical Customers
Table 120. Hepatic Encephalopathy Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Hepatic Encephalopathy Treatment Picture
Figure 2. World Hepatic Encephalopathy Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hepatic Encephalopathy Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 5. World Hepatic Encephalopathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Hepatic Encephalopathy Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 10. China Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 12. Hepatic Encephalopathy Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Hepatic Encephalopathy Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hepatic Encephalopathy Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hepatic Encephalopathy Treatment Markets in 2022
Figure 26. United States VS China: Hepatic Encephalopathy Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hepatic Encephalopathy Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hepatic Encephalopathy Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 32. World Hepatic Encephalopathy Treatment Production Value by Route, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hepatic Encephalopathy Treatment Production Value Market Share by Route in 2022
Figure 34. Oral
Figure 35. Injectable
Figure 36. World Hepatic Encephalopathy Treatment Production Market Share by Route (2018-2029)
Figure 37. World Hepatic Encephalopathy Treatment Production Value Market Share by Route (2018-2029)
Figure 38. World Hepatic Encephalopathy Treatment Average Price by Route (2018-2029) & (US$/Unit)
Figure 39. World Hepatic Encephalopathy Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Hepatic Encephalopathy Treatment Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacy
Figure 42. Retail Pharmacy
Figure 43. Online Pharmacy
Figure 44. World Hepatic Encephalopathy Treatment Production Market Share by Application (2018-2029)
Figure 45. World Hepatic Encephalopathy Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Hepatic Encephalopathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Hepatic Encephalopathy Treatment Industry Chain
Figure 48. Hepatic Encephalopathy Treatment Procurement Model
Figure 49. Hepatic Encephalopathy Treatment Sales Model
Figure 50. Hepatic Encephalopathy Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Hepatic Encephalopathy Treatment Picture
Figure 2. World Hepatic Encephalopathy Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hepatic Encephalopathy Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 5. World Hepatic Encephalopathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hepatic Encephalopathy Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Hepatic Encephalopathy Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 10. China Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Hepatic Encephalopathy Treatment Production (2018-2029) & (K Units)
Figure 12. Hepatic Encephalopathy Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Hepatic Encephalopathy Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Hepatic Encephalopathy Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hepatic Encephalopathy Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hepatic Encephalopathy Treatment Markets in 2022
Figure 26. United States VS China: Hepatic Encephalopathy Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hepatic Encephalopathy Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hepatic Encephalopathy Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hepatic Encephalopathy Treatment Production Market Share 2022
Figure 32. World Hepatic Encephalopathy Treatment Production Value by Route, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hepatic Encephalopathy Treatment Production Value Market Share by Route in 2022
Figure 34. Oral
Figure 35. Injectable
Figure 36. World Hepatic Encephalopathy Treatment Production Market Share by Route (2018-2029)
Figure 37. World Hepatic Encephalopathy Treatment Production Value Market Share by Route (2018-2029)
Figure 38. World Hepatic Encephalopathy Treatment Average Price by Route (2018-2029) & (US$/Unit)
Figure 39. World Hepatic Encephalopathy Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Hepatic Encephalopathy Treatment Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacy
Figure 42. Retail Pharmacy
Figure 43. Online Pharmacy
Figure 44. World Hepatic Encephalopathy Treatment Production Market Share by Application (2018-2029)
Figure 45. World Hepatic Encephalopathy Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Hepatic Encephalopathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Hepatic Encephalopathy Treatment Industry Chain
Figure 48. Hepatic Encephalopathy Treatment Procurement Model
Figure 49. Hepatic Encephalopathy Treatment Sales Model
Figure 50. Hepatic Encephalopathy Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
